Efficacy and safety of telitacicept in systemic lupus erythematosus with lupus nephritis and nephrotic syndrome: a 12-month retrospective cohort study

QR Code

Efficacy and safety of telitacicept in systemic lupus erythematosus with lupus nephritis and nephrotic syndrome: a 12-month retrospective cohort study

BackgroundThis retrospective cohort study evaluated the therapeutic efficacy and safety profile of telitacicept, a novel dual B-cell-activating factor (BAFF)/a proliferation-inducing ligand (April) inhibitor, in managing systemic lupus erythematosus (SLE) patients with lupus nephritis (LN) and nephr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min-Ying Liu, Liu-Jun Li, Ting Li, Hao-Sen Zhu, Chang-Song Lin, Qiang Xu, Qing-Ping Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	telitacicept lupus nephritis nephrotic syndrome efficacy safety
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1613790/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case Report: Full-house renal-limited lupus-like nephritis in pregnancy
by: Lucille Jane Wilkinson, et al.
Published: (2025-06-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Case Report: A patient presenting primarily with psychosis of NPSLE treated with telitacicept, corticosteroids, and immunosuppressants
by: Wei Xie, et al.
Published: (2025-07-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Integrative bioinformatics analysis reveals STAT1, ORC2, and GTF2B as critical biomarkers in lupus nephritis with Monkeypox virus infection
by: Yaojun Wang, et al.
Published: (2025-04-01)

Lupus nephritis – modern aspects of diagnosis and therapy. Part I
by: S. K. Solovyev, et al.
Published: (2024-03-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Relationship between lymphocyte-related parameters and the prognosis of patients with lupus nephritis
by: Wenyi Qi, et al.
Published: (2025-07-01)

Lupus nephritis. Part II, modern ideas about therapy
by: Elena A. Aseeva, et al.
Published: (2024-09-01)

Evaluation of urinary CD163 level as a biomarker for the diagnosis of lupus nephritis
by: Samar Ahmed Eissa, et al.
Published: (2025-03-01)

Programmed immunoadsorption with regeneration of adsoption columns in the treatment of lupus nephritis
by: A. A. Sokolov, et al.
Published: (2020-09-01)

Case Report: A 10-Year-Old Girl with Systemic Lupus Erythematosus, Lupus Nephritis, Normotension On Control, Underweight, And Short Stature
by: Khansa Pinasti Anjarsari, et al.
Published: (2021-09-01)

General principles in the treatment of lupus nephritis with the prevention of cardiovascular events
by: Т. A. Panafidina, et al.
Published: (2018-12-01)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II
by: N. L. Kozlovskaya, et al.
Published: (2021-02-01)

NEPHROTIC EDEMATA: WHY THERAPY IS NOT ALWAYS EFFECTIVE?
by: A. M. Rivkin
Published: (2013-11-01)

<i>FCGR2A</i>-131R Is Associated with Lupus Nephritis Rather than Non-Lupus Nephritis SLE in an Indigenous African Caribbean Population
by: Fatima Radouani, et al.
Published: (2025-06-01)

The role of repeat kidney biopsy in patients with lupus nephritis (case report)
by: N. Yu. Nikishin, et al.
Published: (2024-04-01)

Mediterranean fever gene variants may prevent the development of lupus nephritis in Japanese patients with systemic lupus erythematosus
by: Yushiro Endo, et al.
Published: (2025-07-01)

Case report and literature review: IgG4-related tubulointerstitial nephritis coexistent with systemic lupus erythematosus
by: Xingfu Ji, et al.
Published: (2025-07-01)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I
by: N. L. Kozlovskaya, et al.
Published: (2020-11-01)

Diagnostic Determinants of Proliferative Lupus Nephritis Based on Clinical and Laboratory Parameters: A Diagnostic Study
by: Aida Lydia, et al.
Published: (2018-06-01)

Diagnostic Determinants of Proliferative Lupus Nephritis Based on Clinical and Laboratory Parameters: A Diagnostic Study
by: Aida Lydia, et al.
Published: (2018-06-01)

Single-cell spatial transcriptomics reveals pathogenic mechanism of renal fibrosis in imiquimod-induced lupus nephritis in mice
by: Yanan Xing, et al.
Published: (2025-09-01)

2024 ACR guidelines on screening, treatment, and management of patients with lupus nephritis
by: E. A. Aseeva, et al.
Published: (2025-06-01)

SGLT2 inhibitors in lupus nephritis: a multicentric study in Latin America
by: José L. Daza, et al.
Published: (2025-04-01)

Clinicopathological Features of Lupus Nephritis Patients in North-East India; A Single Center Retrospective Observational Study
by: Shahzad Alam, et al.
Published: (2021-12-01)

Clinicopathologic Spectrum of Nephrotic Syndrome in Elderly
by: Sheikh Zubair, et al.
Published: (2023-04-01)

Efficacy and safety of belimumab therapy for patients with lupus nephritis: A meta‐analysis and a propensity score‐matched case–control study
by: Kai Zhang, et al.
Published: (2023-07-01)

Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis
by: Ai Yi-ying, et al.
Published: (2025-06-01)

Management of Nephrotic Syndrome in Pediatric Patients Treated by Different Steroid Regimens
by: Valeria Chirico, et al.
Published: (2025-07-01)

Mycophenolate mofetil versus cyclophosphamide, in combination with prednisolone for lupus nephritis induction treatment: Findings from a prospective observational study
by: Rakhesh LR, et al.
Published: (2025-07-01)

Evaluating Activity and Chronicity Indices in Lupus Nephritis Using the Recent NIHModified Activity Index Scores: A Comprehensive Correlation Analysis with Renal Function
by: Rabia Saleem, Humaira Nasir, Zafar Ali, Kanza Huma Zia, Anum Iqtidar, Nadia Hassan
Published: (2025-07-01)

Identification of HLA haplotypes as genetic markers of glomerulonephritis with refractory nephrotic syndrome
by: S. I. Kudryashov, et al.
Published: (2024-07-01)

Immunological, mediated with IgE and associated with herpesvirus infection, phenotypes of nephrotic syndrome among children
by: R. A. Belovolova, et al.
Published: (2023-03-01)

CYTOKINE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Maria Eduardovna Tsanyan, et al.
Published: (2013-12-01)

A Case Report of Al-Amyloidosis with «Hepatic Disguise» of Nephrotic Syndrome
by: A. A. Kozlova, et al.
Published: (2024-06-01)

Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome
by: Bartholomeus T. van den Berge, et al.
Published: (2025-07-01)

A Systematic Review of Treatment for Acute Interstitial Nephritis
by: Yalin Yu, et al.
Published: (2025-08-01)

Combined Network Pharmacology, Transcriptomics and Metabolomics Strategies Reveal the Mechanism of Action of Lang Chuang Wan to Ameliorate Lupus Nephritis in MRL/lpr Mice
by: Cuicui Li, et al.
Published: (2025-06-01)

Study of Urinary Alpha Glutathione-S-Transferase (Alpha GST) in Children with Idiopathic Nephrotic Syndrome
by: Manal Abdel-Salam, et al.
Published: (2020-08-01)